MarketBeat Instant News Alerts 2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Niu Technologies (NASDAQ:NIU)MarketBeatWeiss Ratings reissued a "sell (d-)" rating on shares of Niu Technologies in a report on Saturday.NASDAQ:NIURead Weiss Ratings Reaffirms "Sell (D-)" Rating for Niu Technologies (NASDAQ:NIU)2 hours agoNIP Group's (NIPG) "Sell (E+)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings restated a "sell (e+)" rating on shares of NIP Group in a research report on Saturday.NASDAQ:NIPGRead NIP Group's (NIPG) "Sell (E+)" Rating Reiterated at Weiss Ratings2 hours agoNice (NASDAQ:NICE) Downgraded by Weiss Ratings to "Sell (D+)"MarketBeatWeiss Ratings downgraded Nice from a "hold (c-)" rating to a "sell (d+)" rating in a report on Saturday.NASDAQ:NICERead Nice (NASDAQ:NICE) Downgraded by Weiss Ratings to "Sell (D+)"2 hours agoWeiss Ratings Reaffirms Sell (D+) Rating for Natural Health Trends (NASDAQ:NHTC)MarketBeatWeiss Ratings reiterated a "sell (d+)" rating on shares of Natural Health Trends in a report on Saturday.NASDAQ:NHTCRead Weiss Ratings Reaffirms Sell (D+) Rating for Natural Health Trends (NASDAQ:NHTC)2 hours agoNeurogene's (NGNE) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Neurogene in a research report on Saturday.NASDAQ:NGNERead Neurogene's (NGNE) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Buy (B)" Rating for Netflix (NASDAQ:NFLX)MarketBeatWeiss Ratings reissued a "buy (b)" rating on shares of Netflix in a report on Saturday.NASDAQ:NFLXRead Weiss Ratings Reiterates "Buy (B)" Rating for Netflix (NASDAQ:NFLX) Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened6Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade7HC Wainwright Has Positive Outlook of Plug Power Q3 Earnings8HCM II Acquisition (NASDAQ:HOND) Stock Price Down 10.9% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoNextDecade's (NEXT) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:NEXTRead NextDecade's (NEXT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoNexxen International's (NEXN) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:NEXNRead Nexxen International's (NEXN) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoNexMetals Mining's (NEXM) "Sell (E+)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NEXMRead NexMetals Mining's (NEXM) "Sell (E+)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C) Rating for NewtekOne (NASDAQ:NEWT)MarketBeatNASDAQ:NEWTRead Weiss Ratings Reiterates Hold (C) Rating for NewtekOne (NASDAQ:NEWT)2 hours agoWeiss Ratings Reiterates Sell (D) Rating for Nabors Energy Transition Corp. II (NASDAQ:NETD)MarketBeatNASDAQ:NETDRead Weiss Ratings Reiterates Sell (D) Rating for Nabors Energy Transition Corp. II (NASDAQ:NETD)2 hours agoNational Energy Services Reunited (NASDAQ:NESR) Earns "Hold (C)" Rating from Weiss RatingsMarketBeatNASDAQ:NESRRead National Energy Services Reunited (NASDAQ:NESR) Earns "Hold (C)" Rating from Weiss Ratings2 hours agoNephros' (NEPH) "Hold (C)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NEPHRead Nephros' (NEPH) "Hold (C)" Rating Reiterated at Weiss Ratings2 hours agoNeoVolta's (NEOV) "Sell (E+)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NEOVRead NeoVolta's (NEOV) "Sell (E+)" Rating Reiterated at Weiss Ratings2 hours agoNeonode (NASDAQ:NEON) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:NEONRead Neonode (NASDAQ:NEON) Earns Sell (D-) Rating from Weiss Ratings2 hours agoNeogen's (NEOG) Sell (E+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NEOGRead Neogen's (NEOG) Sell (E+) Rating Reiterated at Weiss Ratings2 hours agoNewegg Commerce (NASDAQ:NEGG) Receives Sell (E+) Rating from Weiss RatingsMarketBeatNASDAQ:NEGGRead Newegg Commerce (NASDAQ:NEGG) Receives Sell (E+) Rating from Weiss Ratings2 hours agoNortheast Community Bancorp (NASDAQ:NECB) Cut to Hold (C+) at Weiss RatingsMarketBeatNASDAQ:NECBRead Northeast Community Bancorp (NASDAQ:NECB) Cut to Hold (C+) at Weiss Ratings2 hours agoNordson (NASDAQ:NDSN) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNASDAQ:NDSNRead Nordson (NASDAQ:NDSN) Given "Hold (C)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for nCino (NASDAQ:NCNO)MarketBeatNASDAQ:NCNORead Weiss Ratings Reaffirms Sell (D-) Rating for nCino (NASDAQ:NCNO)2 hours agoNBT Bancorp's (NBTB) Hold (C+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:NBTBRead NBT Bancorp's (NBTB) Hold (C+) Rating Reaffirmed at Weiss Ratings2 hours agoNeurocrine Biosciences (NASDAQ:NBIX) Receives "Hold (C+)" Rating from Weiss RatingsMarketBeatNASDAQ:NBIXRead Neurocrine Biosciences (NASDAQ:NBIX) Receives "Hold (C+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Hold (C-)" Rating for NB Bancorp (NASDAQ:NBBK)MarketBeatNASDAQ:NBBKRead Weiss Ratings Reaffirms "Hold (C-)" Rating for NB Bancorp (NASDAQ:NBBK)2 hours agoNioCorp Developments' (NB) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:NBRead NioCorp Developments' (NB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoNavient's (NAVI) Sell (D+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NAVIRead Navient's (NAVI) Sell (D+) Rating Reiterated at Weiss Ratings2 hours agoNautilus Biotechnology (NASDAQ:NAUT) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:NAUTRead Nautilus Biotechnology (NASDAQ:NAUT) Earns Sell (D-) Rating from Weiss Ratings2 hours agoNature's Sunshine Products (NASDAQ:NATR) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNASDAQ:NATRRead Nature's Sunshine Products (NASDAQ:NATR) Given "Hold (C)" Rating at Weiss Ratings2 hours agoNewAmsterdam Pharma (NASDAQ:NAMS) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:NAMSRead NewAmsterdam Pharma (NASDAQ:NAMS) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Hold (C) Rating for Niagen Bioscience (NASDAQ:NAGE)MarketBeatNASDAQ:NAGERead Weiss Ratings Reaffirms Hold (C) Rating for Niagen Bioscience (NASDAQ:NAGE)2 hours agoMYR Group's (MYRG) "Hold (C+)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:MYRGRead MYR Group's (MYRG) "Hold (C+)" Rating Reiterated at Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025This dark force is about to change everythingFrom Porter & Company (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025Move $1,000 into this stock before Nov 6From Altimetry (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
